Mesoblast (MESO) Cash from Operations: 2015-2025
Historic Cash from Operations for Mesoblast (MESO) over the last 11 years, with Jun 2025 value amounting to -$50.0 million.
- Mesoblast's Cash from Operations fell 17.16% to -$16.3 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$63.3 million, marking a year-over-year increase of 3.82%. This contributed to the annual value of -$50.0 million for FY2025, which is 3.18% down from last year.
- According to the latest figures from FY2025, Mesoblast's Cash from Operations is -$50.0 million, which was down 3.18% from -$48.5 million recorded in FY2024.
- Mesoblast's Cash from Operations' 5-year high stood at -$48.5 million during FY2024, with a 5-year trough of -$100.7 million in FY2021.
- Its 3-year average for Cash from Operations is -$53.9 million, with a median of -$50.0 million in 2025.
- As far as peak fluctuations go, Mesoblast's Cash from Operations tumbled by 99.83% in 2021, and later spiked by 34.71% in 2022.
- Mesoblast's Cash from Operations (Yearly) stood at -$100.7 million in 2021, then soared by 34.71% to -$65.8 million in 2022, then increased by 3.82% to -$63.3 million in 2023, then increased by 23.41% to -$48.5 million in 2024, then dropped by 3.18% to -$50.0 million in 2025.